2 Nasdaq 100 Stocks to Buy Hand Over Fist Right Now
When there are bargains on stocks with long-term appeal, astute investors make sure to get a few shares while the getting is good. And if you're looking for exposure to growth, the stocks listed on the Nasdaq-100 Index -- which is part of the Nasdaq Composite -- is a good place to start. In that vein, let's discuss a pair of monster growth stocks that are worth buying hand-over-fist right now.
Image source: Getty Images.
In truth, Moderna (NASDAQ: MRNA) is a bit of a contrarian purchase at the moment as nobody expects it to one-up its 2022 top line of nearly $19 billion now that sales of its coronavirus vaccine are expected to fall to as low as $5 billion in 2023. And there's little to suggest that demand for its shots will surge to reach the heights of the last couple of years ever again.
Source Fool.com
